Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Elizabeth Yeu
AddedMar 31, 2024
UpdatedMay 31, 2026
Elizabeth Yeu

Elizabeth Yeu

Board Member, Tarsus Pharmaceuticals

LinkedIn

Elizabeth Yeu's Career

Tarsus Pharmaceuticals
Tarsus Pharmaceuticals

Irvine, CA, US

Board Member· Board
STAAR Surgical
STAAR Surgical

Monrovia, CA, US

Board Member· Board
Ocular Science
Ocular Science

Manhattan Beach, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Elizabeth Yeu's Career

Tarsus Pharmaceuticals
Tarsus Pharmaceuticals
Public$410.6M2512017Irvine, CA, US
Board Member· Board

Leadership at Tarsus Pharmaceuticals

Bobak AzamianBobak AzamianBoard Member
Andrew D. GoldbergAndrew D. GoldbergBoard Member

Similar to Tarsus Pharmaceuticals

Telsar PharmaTelsar PharmaBridgewater Township, NJ, USDrugs, Pharmaceuticalsest. 2012Telsar PharmaBridgewater Township, NJ, US · est. 2012

Innovative drug developer for inflammatory bowel disease.

Series A · $14M5
Tigris PharmaceuticalsTigris PharmaceuticalsBonita Springs, FL, USCancer Treatmentsest. 2005Tigris PharmaceuticalsBonita Springs, FL, US · est. 2005

Tigris Pharmaceuticals: Innovating biopharmaceutical solutions for cancer and other medical needs.

Series C · $32.5M6
Surface PharmaceuticalsSurface PharmaceuticalsDelaware, USPharmaceuticalsest. 2017Surface PharmaceuticalsDelaware, US · est. 2017

Delaware-based Surface Pharmaceuticals develops biotech solutions for dry eye diseases, serving California.

Series A · $46.8M8
Arcutis BiotherapeuticsArcutis BiotherapeuticsWestlake Village, CA, USBiopharmaceuticalsest. 2016Arcutis BiotherapeuticsWestlake Village, CA, US · est. 2016

Founded in 2016, Arcutis is a clinical-stage biopharmaceutical company innovating in medical dermatology.

Public · $683.5M268
STAAR Surgical
STAAR Surgical
Public9641982Monrovia, CA, US
Board Member· Board

Leadership at STAAR Surgical

Lou SilvermanLou SilvermanBoard Member
Stephen FarrellStephen FarrellBoard Member
Gil KlimanGil KlimanBoard Member
Don BaileyDon BaileyBoard Member
Thomas FrinziThomas FrinziBoard Member

Similar to STAAR Surgical

AlconAlconVernier, Canton of Geneva, CHContact Lenses, Surgical Productsest. 1945AlconVernier, Canton of Geneva, CH · est. 1945

Alcon Inc. is a global medical company specializing in the manufacture of eye care products.

Public24.4k
RxSightRxSightAliso Viejo, CA, USMedical Devicesest. 1997RxSightAliso Viejo, CA, US · est. 1997

RxSight®, based in California, is the pioneer in adjustable intraocular lenses, revolutionizing cataract surgery.

Public · $236M292
ReaLensReaLensAustin, TX, USOphthalmic Devicesest. 2008ReaLensAustin, TX, US · est. 2008

ReaLens, LLC: Innovating in ophthalmic devices with a patented Iris Expander and a unique IntraOcular Lens, enhancing vision for the aging population.

Angel · $100k3k
ClearsightClearsightAurora, CO, USIntraocular Lensesest. 2012ClearsightAurora, CO, US · est. 2012

ClearSight develops premium intraocular lenses for post-cataract surgery vision enhancement.

Pre-Seed · $1M5
Ocular Science
Ocular Science
Seed$175.1k462015Manhattan Beach, CA, US
Board Member· Board

Leadership at Ocular Science

Anthony SampietroAnthony SampietroCo-Founder
Damien GoldbergDamien GoldbergCo-Founder

Similar to Ocular Science

EyeScience LabsEyeScience LabsPowell, OH, USEye Health, Supplementsest. 2007EyeScience LabsPowell, OH, US · est. 2007

EyeScience Labs: Innovating natural eye health formulas, backed by leading ophthalmologists and scientists.

Pre-Seed · $1.2M11
Ocular TherapeutixOcular TherapeutixBedford, MA, USOphthalmic Therapiesest. 2006Ocular TherapeutixBedford, MA, US · est. 2006

Ocular Therapeutix, Inc.: Global biopharma innovator in hydrogel-based ophthalmic therapies.

Public · $386.5M274
EyeCyteEyeCyteLos Angeles, CA, USTherapeuticsest. 2005EyeCyteLos Angeles, CA, US · est. 2005

EyeCyte: Developing novel therapeutics for neovascular and degenerative retinal diseases.

Series A · $3M5
MediPrint OphthalmicsMediPrint OphthalmicsSan Diego, CA, USPharmaceuticalsest. 2001MediPrint OphthalmicsSan Diego, CA, US · est. 2001

San Diego-based MediPrint Ophthalmics develops and commercializes proprietary ocular drugs to protect sight.

Series A · $7M7

Elizabeth Yeu's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Elizabeth Yeu

Lloyd Paul AielloLloyd Paul AielloBoard Member · Harvard Medical SchoolSteve CharlesSteve CharlesBoard Member · CamplexMichael AbramoffMichael AbramoffBoard Member · Digital DiagnosticsTaylor WhitmanTaylor WhitmanBoard Member · Mivi NeuroscienceSean IanchulevSean IanchulevBoard Member · Hyperion DeFiJerry LegertonJerry LegertonCo-Founder · Innovega